Avotaciclib
Modify Date: 2025-08-27 06:17:03
Avotaciclib structure
|
Common Name | Avotaciclib | ||
|---|---|---|---|---|
| CAS Number | 1983983-41-0 | Molecular Weight | 281.27 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C13H11N7O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of AvotaciclibAvotaciclib (BEY1107) is an orally active cyclin dependent kinase 1 (CDK1) inhibitor. Avotaciclib can be used for the research of cancer[1]. |
| Name | Avotaciclib |
|---|
| Description | Avotaciclib (BEY1107) is an orally active cyclin dependent kinase 1 (CDK1) inhibitor. Avotaciclib can be used for the research of cancer[1]. |
|---|---|
| Related Catalog | |
| Target |
CDK1 |
| In Vitro | Avotaciclib is an orally active cyclin dependent kinase 1 (CDK1) inhibitor [1]. |
| References |
| Molecular Formula | C13H11N7O |
|---|---|
| Molecular Weight | 281.27 |
| InChIKey | VFVAQKKPFOPZEA-UHFFFAOYSA-N |
| SMILES | Nc1nccc(-c2ccc(O)c(-c3ccnc(N)n3)n2)n1 |